Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Sees Large Decrease in Short Interest

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totaling 63,687 shares, a decline of 35.5% from the March 15th total of 98,761 shares. Currently, 1.1% of the shares of the stock are short sold. Based on an average trading volume of 248,199 shares, the short-interest ratio is presently 0.3 days.

Hedge Funds Weigh In On Defiance Daily Target 2X Long LLY ETF

An institutional investor recently bought a new position in Defiance Daily Target 2X Long LLY ETF stock. Jump Financial LLC acquired a new stake in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 9,186 shares of the company’s stock, valued at approximately $234,000. Jump Financial LLC owned approximately 0.54% of Defiance Daily Target 2X Long LLY ETF at the end of the most recent reporting period.

Defiance Daily Target 2X Long LLY ETF Price Performance

NYSEARCA LLYX traded down $0.24 during midday trading on Tuesday, hitting $17.34. The company had a trading volume of 239,687 shares, compared to its average volume of 372,393. The firm has a 50-day moving average price of $20.09 and a 200-day moving average price of $21.39. Defiance Daily Target 2X Long LLY ETF has a twelve month low of $9.60 and a twelve month high of $28.44.

Defiance Daily Target 2X Long LLY ETF Company Profile

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.